Condition: Nasopharyngeal Carcinoma · Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University
To compare the effectiveness and toxicity of nedaplatin versus cisplatin in induction chemotherapy combined with concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma.
This description comes directly from the study's public registry record.
Jinquan Liu, M.D · 0086-137-1086-6485 · 609149209@qq.com
Bin Qi, M.D · 0086-135-8058-0985 · qibin020@126.com
Always discuss trial participation with your own doctor first.
| Department of radiotherapy(Section 5),Affiliated Cancer Hospital & Institute of Guangzhou Medical University | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04437329